Self-selection Study of the Toothwave Toothbrush

NCT ID: NCT04023097

Last Updated: 2020-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-02

Study Completion Date

2019-07-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study objective is to test the Silk'n Toothwave self-selection, by potential end users. Additionally, this study will evaluate if contraindicated subjects will self-exclude from use of the device and the ability to understand accurately the labeling content (box and user manual).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Silk'n Toothwave Device, in its original packaging, along with the user manual will be provided to the patient in a simulated home use environment. The patient labeling will be in the format intended for distribution.

All subjects will sign an informed consent before any study activity. Five (5) potential end users and Additional five (5) contraindicated subjects will be screened for this self-selection study. Subjects will be provided with the device in its original packaging and will be evaluated for their ability to decide if they are eligible or they should self-exclude themselves from use of the device based solely on reading the device labeling (box and user manual).

Once the subjects complete reviewing the labeling materials (box and user manual) they will be requested to perform a labeling comprehension exam for testing the ability to correctly understand the labeling content.

The study will not include treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingivitis Plaque Calculus Tooth Discoloration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

5 participants are suppose to exclude themselves from the use of the device, while the 5 others should claim they can use it.
Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants
Before they start their part in the study, participants won't be aware if they can use the brush or not.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Toothwave contraindicated subject

the Toothwave toothbrush is contraindicated for people in certain conditions, e.g. pregnant or nursing women, people with pacemaker and more.

This arm is assembled from contraindicated subject, who should exclude themselves from use of the device, based on the user manual and box sleeve.

Group Type EXPERIMENTAL

Toothwave toothbrush

Intervention Type DEVICE

Subjects get the device's box with the user manual and the device. However, they don't use the device, but only read the user manual and fill questionnaires.

potential users of the Toothwave device

The control arm is assembled from people who can use the toothbrush and should recognize themselves as potential users.

Group Type ACTIVE_COMPARATOR

Toothwave toothbrush

Intervention Type DEVICE

Subjects get the device's box with the user manual and the device. However, they don't use the device, but only read the user manual and fill questionnaires.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Toothwave toothbrush

Subjects get the device's box with the user manual and the device. However, they don't use the device, but only read the user manual and fill questionnaires.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subject is male or female equal to or greater than 18 years of age.
2. Subject is a potential candidate for purchasing the Silk'n Toothwave Device.
3. Subject is capable of understanding and is willing to sign informed consent.


1. Subject with or an active implant, such as a pacemaker, incontinence device, insulin pump, etc.
2. Subject is pregnant or nursing (lactating).

Exclusion Criteria

1. Current or history of oral cavity cancer or oropharyngeal cancer.
2. Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body.
3. Pregnant or nursing.
4. Any active condition in the oral cavity at the discretion of the investigator.
5. Any surgery in the oral cavity within 3 months prior to treatment, or before complete healing.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Home Skinovations Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Judith Hellman, MD

Role: PRINCIPAL_INVESTIGATOR

Hellman Dermatology Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hellman Dermatology clinic

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DO116508

Identifier Type: -

Identifier Source: org_study_id